Total planned funding: $318,383,595
Allocations
Countries/Regions
| Eswatini | $318,383,595 |
Organizational Types
| Private Contractor | $75,152,965 |
| Unknown | $66,105,443 |
| NGO | $59,354,652 |
| University | $55,798,527 |
| Own Agency | $36,465,328 |
| Host Country Government Agency | $8,691,999 |
| Multi-lateral Agency | $6,636,214 |
| FBO | $5,360,534 |
| Other USG Agency | $4,151,102 |
| Implementing Agency | $666,831 |
Program Areas
| Treatment | $91,415,938 |
| Care | $85,715,404 |
| Prevention | $62,403,590 |
| Governance and Systems | $38,632,911 |
| Management and Operations | $22,925,568 |
| Testing | $17,290,184 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $72,172,127 |
| HBHC: Care: Adult Care and Support | $30,838,683 |
| HKID: Care: Orphans and Vulnerable Children | $30,505,948 |
| HVMS: Management and Operations | $22,925,568 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $22,737,890 |
| HVSI: Strategic Information | $21,774,517 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,878,699 |
| HVCT: Testing: HIV Testing and Counseling | $17,290,184 |
| HVTB: Care: TB/HIV | $16,818,808 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $13,202,083 |
| OHSS: Health Systems Strengthening | $11,210,918 |
| HTXD: Treatment: ARV Drugs | $10,934,747 |
| PDTX: Treatment: Pediatric Treatment | $8,309,064 |
| PDCS: Care: Pediatric Care and Support | $7,551,965 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,709,918 |
| HLAB: Laboratory Infrastructure | $5,647,476 |
| HMBL: Biomedical Prevention: Blood Safety | $875,000 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$52,044,563
Countries/Regions
Columbia University:
$47,666,988
Countries/Regions
Pact, Inc.:
$34,946,905
Countries/Regions
USG Aggregated Agencies:
$19,891,090
Countries/Regions